
Apollo Neuro makes a wearable device that uses gentle, science-backed vibration patterns to train and rebalance the nervous system, helping users reduce stress, improve focus, relax, sleep better, and boost overall resilience without drugs by actively strengthening natural recovery processes.

Investment Details
Funding Round
Series A
Milestones
Funded in 2022 and 2023

About the Founder
Kathryn Fantauzzi
Kathryn Fantauzzi is the co-founder and CEO of Apollo Neuroscience, leading the development of Apollo Neuro, a scientifically validated wearable that improves energy, focus, sleep, and stress resilience. She joined the original University of Pittsburgh research team in 2016 to fund clinical trials and bring the technology to market, launching Apollo Neuro in 2020. With a background in early stage technology commercialization, Kathryn is focused on translating proven science into real world wellbeing solutions.
Real Investors. Real Outcomes.
Start Your Investing Journey with Portfolia
Our live overview sessions are the best way to experience how Portfolia is transforming venture capital and why the experience is unmatched.
- MEET OUR PARTNERS
- LEARN HOW OUR FUNDS WORK
- SEE THE COMPANIES WE'RE BACKING.


